Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - What is the role of public authorities?

What is the role of public authorities?

News
Agenda
Info sheet

By the AVICENN team – Last modification May 2024

The issue of nanotechnology – or that of environmental health in general – has not been established as a public policy in its own right. Governance is split between Europe and Member States, between risk assessors and risk managers and public stakeholders.

This dossier explores the issues of institutional governance of nanotechnology and gives an overview of the panorama in which associations and civil society experts are evolving. It will evolve, as we continue to monitor, synthesize and, in particular, integrate your contributions.

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

27
Jan.
2026
Nanotechnologies and agriculture: a reference framework for responsible practice (AFNOR, online)
On line
Webinar
agriculture
pesticides
standardization
  • Webconference for analysis laboratories, plant fertilizer manufacturers and distributors, public authorities…
  • Moderated by David Krupka, nanotechnologies development manager at AFNOR Normalisation and Emilie Langlois-Bertrand, nantechnologies standardization project manager.
  • In partnership with Armand Masion, CNRS Research Director, and Sandrine Mocoeur, Health, Safety, Environment and Quality Manager at SYNGENTA.
  • This exchange will also be an opportunity to explore the creation of a national platform to identify standardization needs.
  • Website: www.afnor.org/evenement/nanotechnologies-agriculture-cadre-pratique-responsable/

2
Juin
2026
Emerging pathologies and risks (CNMST 2026, Lyon – France)
Lyon
Congress
health
health
occupational health
prevention
risks
  • 8th Congress of Occupational Medicine and Health (CNMST 2026)
  • Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
  • Website: www.medecine-sante-travail.com
26
Juin
2026
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee

Our monitoring, information and actions need you to continue !